Indefinite Delivery Contract SPE2DX16D3901

The federal contract IDV award SPE2DX16D3901 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.00 IDC, with a period of performance through November 23, 2023, is designed to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract encompasses a broad spectrum of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. This IDC serves as a primary vehicle for the DLA to efficiently procure critical pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. The contract was awarded as a full and open competition without any set-aside requirements.